China’s fragmented pharmaceutical industry is expected to undergo a wave of consolidation over the next five years, thanks to more stringent drug quality regulations and a reduction in layers of distribution intermediaries, according to Credit Suisse. Photo: Shutterstock 

Why most small players may not survive China’s pharmaceutical industry consolidation 

Strategy aims to turn China’s predominantly off-patent drug copying pharmaceutical industry into one that’s capable of coming up with innovative patentable products

Topic |   Health in China

TOP PICKS

China’s fragmented pharmaceutical industry is expected to undergo a wave of consolidation over the next five years, thanks to more stringent drug quality regulations and a reduction in layers of distribution intermediaries, according to Credit Suisse. Photo: Shutterstock 
READ FULL ARTICLE